| Year |
Citation |
Score |
| 2007 |
Vlugt-Wensink KD, de Vrueh R, Gresnigt MG, Hoogerbrugge CM, van Buul-Offers SC, de Leede LG, Sterkman LG, Crommelin DJ, Hennink WE, Verrijk R. Preclinical and clinical in vitro in vivo correlation of an hGH dextran microsphere formulation. Pharmaceutical Research. 24: 2239-48. PMID 17929148 DOI: 10.1007/s11095-007-9433-y |
0.37 |
|
| 2005 |
Savino W, Cotta-de-Almeida V, van Buul-Offers SC, Koster JG, Dardenne M. Abnormal thymic microenvironment in insulin-like growth factor-II transgenic mice. Neuroimmunomodulation. 12: 100-12. PMID 15785112 DOI: 10.1159/000083582 |
0.57 |
|
| 2005 |
van Buul-Offers SC, Smink JJ, Gresnigt R, Hamers N, Koedam J, Karperien M. Thyroid hormone, but not parathyroid hormone, partially restores glucocorticoid-induced growth retardation. Pediatric Nephrology (Berlin, Germany). 20: 335-41. PMID 15688232 DOI: 10.1007/s00467-004-1690-y |
0.568 |
|
| 2004 |
Van Doorn J, Gilhuis HJ, Koster JG, Wesseling P, Reddingius RE, Gresnigt MG, Bloemen RJ, Van Muijen GNP, Van Buul-Offers SC. Differential patterns of insulin-like growth factor-I and -II mRNA expression in medulloblastoma Neuropathology and Applied Neurobiology. 30: 503-512. PMID 15488026 DOI: 10.1111/j.1365-2990.2004.00571.x |
0.421 |
|
| 2004 |
Reijnders CM, Koster JG, van Buul-Offers SC. Overexpression of human IGF-II mRNA in the brain of transgenic mice modulates IGFBP-2 gene expression in the medulla oblongata. The Journal of Endocrinology. 182: 445-55. PMID 15350186 |
0.521 |
|
| 2004 |
de Boer L, Hoogerbrugge CM, van Doorn J, van Buul-Offers SC, Karperien M, Wit JM. Plasma insulin-like growth factors (IGFs), IGF-Binding proteins (IGFBPs), acid-labile subunit (ALS) and IGFBP-3 proteolysis in individuals with clinical characteristics of Sotos syndrome. Journal of Pediatric Endocrinology & Metabolism : Jpem. 17: 615-27. PMID 15198293 |
0.361 |
|
| 2003 |
Smink JJ, Buchholz IM, Hamers N, van Tilburg CM, Christis C, Sakkers RJ, de Meer K, van Buul-Offers SC, Koedam JA. Short-term glucocorticoid treatment of piglets causes changes in growth plate morphology and angiogenesis. Osteoarthritis and Cartilage / Oars, Osteoarthritis Research Society. 11: 864-71. PMID 14629962 |
0.373 |
|
| 2003 |
Smink JJ, Gresnigt MG, Hamers N, Koedam JA, Berger R, Van Buul-Offers SC. Short-term glucocorticoid treatment of prepubertal mice decreases growth and IGF-I expression in the growth plate. The Journal of Endocrinology. 177: 381-8. PMID 12773118 |
0.648 |
|
| 2003 |
Rooman RP, Kuijpers G, Gresnigt R, Bloemen R, Koster JG, van Buul-Offers SC. Dexamethasone differentially inhibits thyroxine- or growth hormone-induced body and organ growth of Snell dwarf mice. Endocrinology. 144: 2553-8. PMID 12746318 DOI: 10.1210/en.2003-0062 |
0.551 |
|
| 2002 |
Koedam JA, Smink JJ, van Buul-Offers SC. Glucocorticoids inhibit vascular endothelial growth factor expression in growth plate chondrocytes. Molecular and Cellular Endocrinology. 197: 35-44. PMID 12431793 |
0.363 |
|
| 2002 |
Smink JJ, Koster JG, Gresnigt MG, Rooman R, Koedam JA, Van Buul-Offers SC. IGF and IGF-binding protein expression in the growth plate of normal, dexamethasone-treated and human IGF-II transgenic mice. The Journal of Endocrinology. 175: 143-53. PMID 12379498 |
0.604 |
|
| 2002 |
van Doorn J, Hoogerbrugge CM, Koster JG, Bloemen RJ, Hoekman K, Mudde AH, van Buul-Offers SC. Antibodies directed against the E region of pro-insulin-like growth factor-II used to evaluate non-islet cell tumor-induced hypoglycemia. Clinical Chemistry. 48: 1739-50. PMID 12324491 |
0.34 |
|
| 2002 |
Smink JJ, Koedam JA, Koster JG, van Buul-Offers SC. Dexamethasone-induced growth inhibition of porcine growth plate chondrocytes is accompanied by changes in levels of IGF axis components. The Journal of Endocrinology. 174: 343-52. PMID 12176674 |
0.561 |
|
| 2001 |
van Doorn J, Ringeling AM, Rikken B, van Buul-Offers SC. Plasma levels of insulin-like binding protein-2 in prepubertal short children and its diagnostic value in the evaluation of growth hormone deficiency. Hormone Research. 55: 147-54. PMID 11549877 |
0.442 |
|
| 2001 |
van Kleffens M, Lindenbergh-Kortleve DJ, Koster JG, van Neck JW, Flyvbjerg A, Rasch R, Drop SL, van Buul-Offers SC. The role of the IGF axis in IGFBP-1 and IGF-I induced renal enlargement in Snell dwarf mice. The Journal of Endocrinology. 170: 333-46. PMID 11479130 |
0.513 |
|
| 2001 |
Van Doorn J, Cornelissen AJ, Van Buul-Offers SC. Plasma levels of insulin-like growth factor binding protein-4 (IGFBP-4) under normal and pathological conditions. Clinical Endocrinology. 54: 655-64. PMID 11380497 |
0.401 |
|
| 2000 |
Koedam JA, Hoogerbrugge CM, Van Buul-Offers SC. Differential regulation of IGF-binding proteins in rabbit costal chondrocytes by IGF-I and dexamethasone. The Journal of Endocrinology. 165: 557-67. PMID 10828839 |
0.501 |
|
| 2000 |
Van Buul-Offers SC, Van Kleffens M, Koster JG, Lindenbergh-Kortleve DJ, Gresnigt MG, Drop SL, Hoogerbrugge CM, Bloemen RJ, Koedam JA, Van Neck JW. Human insulin-like growth factor (IGF) binding protein-1 inhibits IGF-I-stimulated body growth but stimulates growth of the kidney in snell dwarf mice. Endocrinology. 141: 1493-9. PMID 10746655 DOI: 10.1210/endo.141.4.7418 |
0.661 |
|
| 1999 |
Rooman R, Koster G, Bloemen R, Gresnigt R, van Buul-Offers SC. The effect of dexamethasone on body and organ growth of normal and IGF-II-transgenic mice. The Journal of Endocrinology. 163: 543-52. PMID 10588828 |
0.608 |
|
| 1999 |
Smink JJ, Koster JG, Hendriks-Stegeman BI, Van Buul-Offers SC. Insulin-like growth factor (IGF) II induced changes in expression of IGF binding proteins in lymphoid tissues of hIGF-II transgenic mice. Endocrinology. 140: 5876-82. PMID 10579353 DOI: 10.1210/endo.140.12.7174 |
0.613 |
|
| 1999 |
Van Doorn J, Ringeling AM, Shmueli SS, Kuijpers MC, Hokken-Koelega AC, van Buul-Offers SC, Jansen M. Circulating levels of human insulin-like growth factor binding protein-6 (IGFBP-6) in health and disease as determined by radioimmunoassay. Clinical Endocrinology. 50: 601-9. PMID 10468926 |
0.438 |
|
| 1998 |
van Buul-Offers SC, Kooijman R. The role of growth hormone and insulin-like growth factors in the immune system. Cellular and Molecular Life Sciences : Cmls. 54: 1083-94. PMID 9817987 DOI: 10.1007/s000180050237 |
0.491 |
|
| 1998 |
Koedam JA, Hoogerbrugge CM, van Buul-Offers SC. Insulin-like growth factor-binding protein-3 protease activity in Snell normal and Pit-1 deficient dwarf mice. The Journal of Endocrinology. 157: 295-303. PMID 9659293 |
0.574 |
|
| 1997 |
Koedam JA, Hoogerbrugge CM, Van Buul-Offers SC. Insulin-like growth factor binding proteins-3 and -5 form sodium dodecyl sulfate-stable multimers. Biochemical and Biophysical Research Communications. 240: 707-14. PMID 9398631 DOI: 10.1006/bbrc.1997.7726 |
0.329 |
|
| 1997 |
Kooijman R, van Buul-Offers SC, Scholtens LE, Reijnen-Gresnigt RG, Zegers BJ. T and B cell development in pituitary deficient insulin-like growth factor-II transgenic dwarf mice. The Journal of Endocrinology. 155: 165-70. PMID 9390019 |
0.579 |
|
| 1997 |
Op De Beeck L, Verlooy JE, Van Buul-Offers SC, Du Caju MV. Detection of serum insulin-like growth factor binding proteins on western ligand blots by biotinylated IGF and enhanced chemiluminescence. The Journal of Endocrinology. 154: R1-5. PMID 9291848 |
0.304 |
|
| 1997 |
Kooijman R, Malur A, Van Buul-Offers SC, Hooghe-Peters EL. Growth hormone expression in murine bone marrow cells is independent of the pituitary transcription factor Pit-1. Endocrinology. 138: 3949-55. PMID 9275086 DOI: 10.1210/endo.138.9.5414 |
0.402 |
|
| 1997 |
Van der Ven LT, Roholl PJ, Gloudemans T, Van Buul-Offers SC, Welters MJ, Bladergroen BA, Faber JA, Sussenbach JS, Den Otter W. Expression of insulin-like growth factors (IGFs), their receptors and IGF binding protein-3 in normal, benign and malignant smooth muscle tissues. British Journal of Cancer. 75: 1631-40. PMID 9184179 DOI: 10.1038/bjc.1997.278 |
0.403 |
|
| 1997 |
Koedam JA, Hoogerbrugge CM, van Buul-Offers SC, Van den Brande JL. Solid-phase assay for insulin-like growth factor (IGF) binding to IGF-binding protein-3: application to the study of the effects of antibodies and heparin. The Journal of Endocrinology. 153: 87-97. PMID 9135573 |
0.423 |
|
| 1997 |
Van der Ven LT, Roholl PJ, Reijnen-Gresnigt MG, Bloemen RJ, van Buul-Offers SC. Expression of insulin-like growth factor II (IGF-II) and histological changes in the thymus and spleen of transgenic mice overexpressing IGF-II. Histochemistry and Cell Biology. 107: 193-203. PMID 9105890 |
0.574 |
|
| 1997 |
Van der Ven LT, Van Buul-Offers SC, Gloudemans T, Roholl PJ, Sussenbach JS, Den Otter W. Histamine-stimulated expression of insulin-like growth factors in human glioma cells. British Journal of Cancer. 75: 1091-7. PMID 9099954 DOI: 10.1038/bjc.1997.189 |
0.541 |
|
| 1996 |
van der Ven LT, Van Buul-Offers SC, Gloudemans T, Bloemen RJ, Roholl PJ, Sussenbach JS, Den Otter W. Modulation of insulin-like growth factor (IGF) action by IGF-binding proteins in normal, benign, and malignant smooth muscle tissues. The Journal of Clinical Endocrinology and Metabolism. 81: 3629-35. PMID 8855813 DOI: 10.1210/jcem.81.10.8855813 |
0.49 |
|
| 1996 |
van Buul-Offers S, Reijnen-Gresnigt R, Bloemen R, Hoogerbrugge C, Van den Brande JL. Co-administration of IGF-binding protein-3 differentially inhibits the IGF-I-induced total body and organ growth of Snell dwarf mice. Progress in Growth Factor Research. 6: 377-83. PMID 8817681 DOI: 10.1016/0955-2235(95)00019-4 |
0.662 |
|
| 1995 |
de Bleser PJ, Jannes P, van Buul-Offers SC, Hoogerbrugge CM, van Schravendijk CF, Niki T, Rogiers V, van den Brande JL, Wisse E, Geerts A. Insulinlike growth factor-II/mannose 6-phosphate receptor is expressed on CCl4-exposed rat fat-storing cells and facilitates activation of latent transforming growth factor-beta in cocultures with sinusoidal endothelial cells. Hepatology (Baltimore, Md.). 21: 1429-37. PMID 7737649 |
0.366 |
|
| 1995 |
van Buul-Offers SC, de Haan K, Reijnen-Gresnigt MG, Meinsma D, Jansen M, Oei SL, Bonte EJ, Sussenbach JS, Van den Brande JL. Overexpression of human insulin-like growth factor-II in transgenic mice causes increased growth of the thymus. The Journal of Endocrinology. 144: 491-502. PMID 7537791 |
0.602 |
|
| 1994 |
van der Ven LT, Gloudemans T, Roholl PJ, van Buul-Offers SC, Bladergroen BA, Welters MJ, Sussenbach JS, den Otter W. Growth advantage of human leiomyoma cells compared to normal smooth-muscle cells due to enhanced sensitivity toward insulin-like growth factor I. International Journal of Cancer. 59: 427-34. PMID 7927953 |
0.45 |
|
| 1994 |
van Buul-Offers SC, Bloemen RJ, Reijnen-Gresnigt MG, van Leiden HA, Hoogerbrugge CM, Van den Brande JL. Insulin-like growth factors-I and -II and their binding proteins during postnatal development of dwarf Snell mice before and during growth hormone and thyroxine therapy. The Journal of Endocrinology. 143: 191-8. PMID 7525829 |
0.688 |
|
| 1994 |
van Buul-Offers SC, Reijnen-Gresnigt MG, Hoogerbrugge CM, Bloemen RJ, Kuper CF, Van den Brande JL. Recombinant insulin-like growth factor-II inhibits the growth-stimulating effect of growth hormone on the liver of Snell dwarf mice. Endocrinology. 135: 977-85. PMID 7520865 DOI: 10.1210/endo.135.3.7520865 |
0.663 |
|
| 1992 |
Kooijman R, Willems M, De Haas CJ, Rijkers GT, Schuurmans AL, Van Buul-Offers SC, Heijnen CJ, Zegers BJ. Expression of type I insulin-like growth factor receptors on human peripheral blood mononuclear cells. Endocrinology. 131: 2244-50. PMID 1425423 DOI: 10.1210/endo.131.5.1425423 |
0.386 |
|
| 1992 |
Kooijman R, Willems M, Rijkers GT, Brinkman A, van Buul-Offers SC, Heijnen CJ, Zegers BJ. Effects of insulin-like growth factors and growth hormone on the in vitro proliferation of T lymphocytes. Journal of Neuroimmunology. 38: 95-104. PMID 1374427 |
0.542 |
|
| 1991 |
Bayne S, Hoogerbrugge CM, Thomsen J, Skriver L, van Buul-Offers SC, van den Brande JL. Primary sequences of insulin-like growth factors 1 and 2 isolated from porcine plasma. Journal of Chromatography. 562: 391-402. PMID 2026706 |
0.35 |
|
| 1991 |
van Doorn J, Oltmans HF, Wit JM, van Buul-Offers SC, Jansen M, van den Brande JL. [Clinical relevance of the measurement of insulin=like growth factors in plasma]. Nederlands Tijdschrift Voor Geneeskunde. 135: 1730-5. PMID 1922527 |
0.303 |
|
| 1990 |
Bovenberg WA, Dauwerse JG, Pospiech HM, Van Buul-Offers SC, Van den Brande JL, Sussenbach JS. Expression of recombinant human insulin-like growth factor I in mammalian cells. Molecular and Cellular Endocrinology. 74: 45-59. PMID 2282979 |
0.415 |
|
| 1990 |
Slootweg MC, Hoogerbrugge CM, de Poorter TL, Duursma SA, van Buul-Offers SC. The presence of classical insulin-like growth factor (IGF) type-I and -II receptors on mouse osteoblasts: autocrine/paracrine growth effect of IGFs? The Journal of Endocrinology. 125: 271-7. PMID 2165120 |
0.542 |
|
| 1990 |
Jansen J, van Buul-Offers SC, Hoogerbrugge CM, Van Den Brande JL. Effects of a single cleavage in insulin-like growth factors I and II on binding to receptors, carrier proteins and antibodies. The Biochemical Journal. 266: 513-20. PMID 2156497 |
0.394 |
|
| 1990 |
Slootweg MC, van Buul-Offers SC, Hoogerbrugge CM, Herrmann-Erlee MP, van den Eijnden-van Raaij AJ, Duursma SA, van Zoelen EJ. Characterization of growth factor activity produced by fetal mouse osteoblasts. The Journal of Endocrinology. 124: 301-9. PMID 1690257 |
0.475 |
|
| 1989 |
van Buul-Offers S, Hoogerbrugge CM, Branger J, Feijlbrief M, Van den Brande JL. Growth-stimulating effects of somatomedin-/insulin-like peptides in Snell dwarf mice. Hormone Research. 29: 229-36. PMID 3220460 DOI: 10.1159/000181009 |
0.571 |
|
| 1989 |
Weima SM, Stet LH, van Rooijen MA, van Buul-Offers SC, van Zoelen EJ, de Laat SW, Mummery CL. Human teratocarcinoma cells express functional insulin-like growth factor I receptors. Experimental Cell Research. 184: 427-39. PMID 2553456 DOI: 10.1016/0014-4827(89)90341-8 |
0.397 |
|
| 1989 |
Jansen J, van Buul-Offers SC, Hoogerbrugge CM, de Poorter TL, Corvol MT, Van den Brande JL. Characterization of specific insulin-like growth factor (IGF)-I and IGF-II receptors on cultured rabbit articular chondrocyte membranes. The Journal of Endocrinology. 120: 245-9. PMID 2538534 |
0.456 |
|
| 1989 |
van Zoelen EJ, Koornneef I, Holthuis JC, Ward-van Oostwaard TM, Feijen A, de Poorter TL, Mummery CL, van Buul-Offers SC. Production of insulin-like growth factors, platelet-derived growth factor, and transforming growth factors and their role in the density-dependent growth regulation of a differentiated embryonal carcinoma cell line. Endocrinology. 124: 2029-41. PMID 2538320 DOI: 10.1210/endo-124-4-2029 |
0.48 |
|
| 1988 |
Slootweg MC, van Buul-Offers SC, Herrmann-Erlee MP, Duursma SA. Direct stimulatory effect of growth hormone on DNA synthesis of fetal chicken osteoblasts in culture. Acta Endocrinologica. 118: 294-300. PMID 3389054 |
0.309 |
|
| 1988 |
van Buul PP, van Buul-Offers SC. Effects of hormone treatment on chromosomal radiosensitivity of somatic and germ cells of Snell's dwarf mice. Mutation Research. 198: 263-8. PMID 3352633 |
0.322 |
|
| 1988 |
Slootweg MC, van Buul-Offers SC, Herrmann-Erlee MP, van der Meer JM, Duursma SA. Growth hormone is mitogenic for fetal mouse osteoblasts but not for undifferentiated bone cells. The Journal of Endocrinology. 116: R11-3. PMID 3351425 |
0.341 |
|
| 1988 |
Wit JM, Schuitema-Dijkstra A, van Buul-Offers S, Opmeer F, Van den Brande JL. Excessive growth in a child with craniopharyngioma and growth hormone deficiency. European Journal of Pediatrics. 147: 658-61. PMID 3181208 DOI: 10.1007/BF00442487 |
0.547 |
|
| 1988 |
van Buul-Offers S, Hoogerbrugge CM, de Poorter TL. The bovine placenta: a specific radioreceptor assay for both insulin-like growth factor I and insulin-like growth factor II. Acta Endocrinologica. 118: 306-13. PMID 2968751 DOI: 10.1530/acta.0.1180306 |
0.391 |
|
| 1986 |
van Buul-Offers S, Ueda I, Van den Brande JL. Biosynthetic somatomedin C (SM-C/IGF-I) increases the length and weight of Snell dwarf mice. Pediatric Research. 20: 825-7. PMID 3748655 DOI: 10.1203/00006450-198609000-00002 |
0.58 |
|
| 1986 |
Smeets T, van Buul-Offers S. Influence of growth hormone and thyroxine on cell kinetics in the proximal tibial growth plate of Snell dwarf mice. Cell and Tissue Kinetics. 19: 161-70. PMID 3698073 DOI: 10.1111/j.1365-2184.1986.tb00726.x |
0.416 |
|
| 1985 |
van Buul-Offers S, Van den Brande JL. Biosynthetic human growth hormone: effects on growth of Snell dwarf mice. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme. 17: 20-4. PMID 3967843 DOI: 10.1055/s-2007-1013437 |
0.494 |
|
| 1984 |
van Buul PP, van Buul-Offers S. Clastogenic effects of biosynthetic human growth hormone in Snell dwarf mice and CHO cells in vitro. Mutation Research. 127: 61-4. PMID 6727903 DOI: 10.1016/0027-5107(84)90140-4 |
0.444 |
|
| 1984 |
van Buul-Offers S. The effects of pituitary, thyroid, pancreatic and sexual hormones on body length and weight and organ weights of Snell dwarf mice. Growth. 48: 101-19. PMID 6724329 |
0.463 |
|
| 1984 |
van der Kamp AW, van Buul-Offers SC, Roza-de Jongh EJ, Feijlbrief M, Branger J, van Rongen E. Growth and differentiation of pluripotent embryonal carcinoma cells in the Snell dwarf mouse. British Journal of Cancer. 50: 479-82. PMID 6534385 |
0.471 |
|
| 1984 |
van Buul-Offers S, Smeets T, Van den Brande JL. Effects of growth hormone and thyroxine on the relation between tibial length and the histological appearance of the proximal tibial epiphysis in Snell dwarf mice. Growth. 48: 166-75. PMID 6469049 |
0.53 |
|
| 1983 |
van Buul PP, van Buul-Offers S. Effect of hormone treatment on spontaneous and radiation-induced chromosomal breakage in normal and dwarf mice. Mutation Research. 106: 237-46. PMID 6818474 DOI: 10.1016/0027-5107(82)90105-1 |
0.528 |
|
| 1983 |
Smeets T, van Buul-Offers S. The influence of growth hormone, somatomedins, prolactin and thyroxine on the morphology of the proximal tibial epiphysis and growth plate of Snell dwarf mice. Growth. 47: 160-73. PMID 6618259 |
0.537 |
|
| 1983 |
Smeets T, van Buul-Offers S. A morphological study of the development of the tibial proximal epiphysis and growth plate of normal and dwarfed Snell mice. Growth. 47: 145-59. PMID 6618258 |
0.473 |
|
| 1983 |
van Buul-Offers S. Hormonal and other inherited growth disturbances in mice with special reference to the Snell dwarf mouse. A review. Acta Endocrinologica. Supplementum. 258: 1-47. PMID 6353833 |
0.537 |
|
| 1983 |
Bijlsma JW, Van Buul-Offers SC. The role of somatomedins in growth regulation. The Netherlands Journal of Medicine. 26: 232-9. PMID 6196649 |
0.372 |
|
| 1982 |
Wauben-Penris PJ, van Buul-Offers SC. Meiotic nondisjunction in male Snell dwarf mice. The Journal of Heredity. 73: 365-9. PMID 7153488 |
0.32 |
|
| 1982 |
van Buul-Offers S, Van den Brande JL. Cellular growth in organs of dwarf mice during treatment with growth hormone, thyroxine and plasma fractions containing somatomedin activity. Acta Endocrinologica. 99: 150-60. PMID 6174009 DOI: 10.1530/acta.0.0990150 |
0.526 |
|
| 1982 |
van Buul-Offers S, Van den Brande JL. Cellular growth in several organs of normal and dwarfed Snell mice. Acta Endocrinologica. 99: 141-9. PMID 6174008 DOI: 10.1530/acta.0.0990141 |
0.371 |
|
| 1981 |
van Buul-Offers S, Van den Brande JL. The growth of different organs of normal and dwarfed Snell mice, before and during growth hormone therapy. Acta Endocrinologica. 96: 46-58. PMID 7456983 DOI: 10.1530/acta.0.0960046 |
0.563 |
|
| 1979 |
Van den Brande JL, van Buul-Offers S. Effect of growth hormone and peptide fractions containing somatomedin activity on growth and cartilage metabolism of Snell dwarfmice. Acta Endocrinologica. 92: 242-57. PMID 494990 DOI: 10.1530/acta.0.0920242 |
0.377 |
|
| Show low-probability matches. |